After T cell receptor (TCR) engagement, an increased IL-2 secretion upon lipoplexes treatment respect to untreated cells (RPMI) was observed in HET C1858T PTPN22 T1D PBMC in comparison to wild type PTPN22 T1D PBMC (7). This evidence concerns the gene PTPN22 and type 1 diabetes mellitus.